A detailed history of Bessemer Group Inc transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 160 shares of CDMO stock, worth $1,976. This represents 0.0% of its overall portfolio holdings.

Number of Shares
160
Holding current value
$1,976
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$6.7 - $12.45 $1,072 - $1,992
160 New
160 $2,000
Q2 2023

Aug 10, 2023

BUY
$12.96 - $20.93 $984 - $1,590
76 Added 7.76%
1,056 $15,000
Q4 2022

Feb 13, 2023

SELL
$12.61 - $18.74 $5.76 Million - $8.56 Million
-456,610 Reduced 99.79%
980 $13,000
Q3 2022

Nov 09, 2022

BUY
$15.33 - $20.36 $7.01 Million - $9.32 Million
457,590 New
457,590 $8.75 Million

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $768M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.